Exploiting genomics to mitigate the public health impact of antimicrobial resistance.

Waddington, Claire; Carey, Megan E; Boinett, Christine J; Higginson, Ellen; Veeraraghavan, Balaji; Baker, Stephen

Waddington, Claire; Carey, Megan E; Boinett, Christine J; Higginson, Ellen; Veeraraghavan, Balaji; Baker, Stephen.

Afiliação

Waddington C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
Carey ME; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Boinett CJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.
Higginson E; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.
Veeraraghavan B; Wellcome Sanger Institute, Hinxton, Cambridge, UK.
Baker S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK.

Genome Med ; 14(1): 15, 2022 02 16.

Article em En | MEDLINE | ID: mdl-35172877

Assuntos

Antibacterianos; Anti-Infecciosos; Animais; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Farmacorresistência Bacteriana/genética; Genômica/métodos; Humanos; Saúde Pública

Palavras-chave

Antimicrobial resistance; Diagnostics; Genomics; Public health; Surveillance; Vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anti-Infecciosos / Antibacterianos Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google